利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

12 条记录 (耗时 0.032 秒)

    Infectious Sindbis virus vectors
    1.
    发明授权
    Infectious Sindbis virus vectors 失效
    传染性辛德毕斯病毒载体

    公开(公告)号：US5217879A

    公开(公告)日：1993-06-08

    申请号：US815602

    申请日：1991-12-27

    申请人： Henry V. Huang ,  Robin Levis ,  Charles M. Rice ,  Sondra Schlesinger ,  Ping Shen ,  Cheng Xiong

    发明人： Henry V. Huang ,  Robin Levis ,  Charles M. Rice ,  Sondra Schlesinger ,  Ping Shen ,  Cheng Xiong

    IPC分类号： C12N7/01 ,  C12N15/86

    CPC分类号： C12N15/86 ,  C12N2760/18843

    摘要： Compositions and methods are disclosed for expressing heterologous coding sequences in host cells. The compositions include infectious Sindbis virus RNA molecules containing at least one heterologous coding sequence inserted within the structural region of the Sindbis virus genome. RNA molecules consisting essentially of a Sindbis virus junction region are also provided. Methods utilizing the novel compositions of the present invention to express heterologous coding sequences in transformed host cells are provided. Methods for producing infectious Sindbis virus particles containing infectious Sindbis virus RNA molecules comprising at least one heterologous coding sequence are provided.This invention was made with government support under grant numbers AI24134, AI11377 and AG05681 awarded by the National Institutes of Health. The government has certain rights in the invention.

    摘要翻译： 公开了用于在宿主细胞中表达异源编码序列的组合物和方法。 组合物包括感染性的辛德比斯病毒RNA分子，其含有插入在辛德比斯病毒基因组的结构区域内的至少一个异源编码序列。 还提供了基本上由辛德毕斯病毒连接区组成的RNA分子。 提供了利用本发明新组合物在转化的宿主细胞中表达异源编码序列的方法。 提供了包含至少一种异源编码序列的含感染性辛德毕斯病毒RNA分子的感染性辛德比斯病毒颗粒的方法。

    Methods for the detection of a novel hepatitis C virus (HCV) terminal 3′ noncoding region
    3.
    发明授权
    Methods for the detection of a novel hepatitis C virus (HCV) terminal 3′ noncoding region 失效
    检测新型丙型肝炎病毒（HCV）终端3'非编码区的方法

    公开(公告)号：US06297003B1

    公开(公告)日：2001-10-02

    申请号：US08897126

    申请日：1997-07-18

    申请人： Charles M. Rice ,  Alexander A. Kolykhalov

    发明人： Charles M. Rice ,  Alexander A. Kolykhalov

    IPC分类号： C12Q170

    CPC分类号： C07K14/005 ,  A61K38/00 ,  A61K39/00 ,  A61K48/00 ,  A61K2039/51 ,  C07K2319/00 ,  C12N2770/24222 ,  C12Q1/707

    摘要： The invention relates to the discovery of a novel RNA sequence at the 3′ terminal sequence of hepatitis C virus (HCV) genome RNA. Included in the invention are the 3′ sequence, its complement, and their use for nucleic-acid based diagnostics and for developing and evaluating novel anti-HCV therapies. This sequence element, which is conserved among HCV genotypes, is likely to be essential for viral replication, and required for construction of full-length HCV cDNA clones capable of yielding infectious RNA, progeny virus or replication-competent HCV replicons. Such functional clones are useful tools for evaluation of therapeutic approaches and as substrates for developing candidate attenuated or inactivated HCV derivatives for vaccination against HCV.

    摘要翻译： 本发明涉及在丙型肝炎病毒（HCV）基因组RNA的3'末端序列上发现新的RNA序列。 本发明包括3'序列，其补体及其用于基于核酸的诊断和用于开发和评估新型抗HCV疗法的用途。 在HCV基因型之间保守的该序列元件可能对于病毒复制是必需的，并且是构建能够产生感染性RNA，后代病毒或复制能力的HCV复制子的全长HCV cDNA克隆所必需的。 这种功能性克隆是用于评价治疗方法的有用工具，以及用于开发用于针对HCV接种的候选减毒或灭活的HCV衍生物的底物。

    Yarn stop-motion device
    4.
    发明授权
    Yarn stop-motion device 失效
    纱线停止运动装置

    公开(公告)号：US3938311A

    公开(公告)日：1976-02-17

    申请号：US472829

    申请日：1974-05-23

    申请人： Charles M. Rice

    发明人： Charles M. Rice

    IPC分类号： D01H13/18 ,  D01H13/16

    CPC分类号： D01H13/188 ,  Y10T225/393

    摘要： A yarn stop-motion device for use with a yarn-processing apparatus comprising yarn break-detector means and yarn-severing means positioned close to each other and preferably combined in a single unit. This device is characterized in that the point at which the yarn break is detected by the device and the point at which the yarn is severed by the device are both positioned above or on the same side of the yarn-processing apparatus associated with the device.

    摘要翻译： 一种与纱线处理装置一起使用的纱线停止运动装置，包括断纱检测装置和彼此靠近并优选组合在一个单元中的纱线切断装置。 该装置的特征在于，通过装置检测到纱线断裂的点和由装置切断纱线的点都位于与装置相关联的纱线处理装置的同一侧上或与纱线处理装置相同的一侧。

    HCV Variants and Related Methods
    5.
    发明申请
    HCV Variants and Related Methods 有权
    HCV变异及相关方法

    公开(公告)号：US20080213750A1

    公开(公告)日：2008-09-04

    申请号：US11960391

    申请日：2007-12-19

    申请人： Charles M. Rice ,  Keril J. Blight

    发明人： Charles M. Rice ,  Keril J. Blight

    IPC分类号： C12Q1/70 ,  C12N15/00 ,  C12N15/82 ,  C12N5/02 ,  C12N5/00

    CPC分类号： C12Q1/707

    摘要： HCV variants are described. The variants include polynucleotides comprising non-naturally occurring HCV sequences and HCV variants that have a transfection efficiency and ability to survive subpassage greater than HCV that have wild-type polyprotein coding regions. Expression vectors comprising the above polynucleotides and HCV variants are also described, as are the provision of cells and host cells comprising the expression vectors. Methods for identifying a cell line that is permissive for infection with HCV are also provided, as are vaccines comprising the above polynucleotides in a pharmaceutically acceptable carrier. Additionally, methods for inducing immunoprotection to HCV in a primate are described, as are methods for testing a compound for inhibiting HCV replication.

    摘要翻译： 描述了HCV变体。 变体包括包含非天然存在的HCV序列和HCV变体的多核苷酸，其具有转染效率和能够存活大于具有野生型多蛋白编码区的HCV的亚临床的能力。 还描述了包含上述多核苷酸和HCV变体的表达载体，以及提供包含表达载体的细胞和宿主细胞。 还提供了鉴定用于感染HCV的细胞系的方法，以及在药学上可接受的载体中包含上述多核苷酸的疫苗。 此外，还描述了在灵长类动物中诱导HCV的免疫保护的方法，以及用于测试抑制HCV复制的化合物的方法。

    HCV variants
    6.
    发明授权
    HCV variants 有权
    HCV变体

    公开(公告)号：US07338759B1

    公开(公告)日：2008-03-04

    申请号：US10276051

    申请日：2001-05-23

    申请人： Charles M. Rice ,  Keril J. Blight

    发明人： Charles M. Rice ,  Keril J. Blight

    IPC分类号： C12Q1/70 ,  C12Q1/68 ,  C12N15/09 ,  C12P21/00 ,  C12N7/02 ,  C12N5/10 ,  C07H21/00

    CPC分类号： A61K39/12 ,  A61K2039/53 ,  C12N7/00 ,  C12N15/86 ,  C12N2770/24222 ,  C12N2770/24243 ,  C12N2770/24251 ,  C12Q1/18 ,  G01N2333/18 ,  G01N2500/10

    摘要： HCV variants are described. The variants include polynucleotides comprising non-naturally occurring HCV sequences and HCV variants that have a transfection efficiency and ability to survive subpassage greater than HCV that have wild-type polyprotein coding regions. Expression vectors comprising the above polynucleotides and HCV variants are also described, as are the provision of cells and host cells comprising the expression vectors. Methods for identifying a cell line that is permissive for infection with HCV are also provided, as are vaccines comprising the above polynucleotides in a pharmaceutically acceptable carrier. Additionally, methods for inducing immunoprotection to HCV in a primate are described, as are methods for testing a compound for inhibiting HCV replication.

    摘要翻译： 描述了HCV变体。 变体包括包含非天然存在的HCV序列和HCV变体的多核苷酸，其具有转染效率和能够存活大于具有野生型多蛋白编码区的HCV的亚临床的能力。 还描述了包含上述多核苷酸和HCV变体的表达载体，以及提供包含表达载体的细胞和宿主细胞。 还提供了鉴定用于感染HCV的细胞系的方法，以及在药学上可接受的载体中包含上述多核苷酸的疫苗。 此外，还描述了在灵长类动物中诱导HCV的免疫保护的方法，以及用于测试抑制HCV复制的化合物的方法。

    Indicating device for yarn crimping wheel teeth spacing adjustment
    8.
    发明授权
    Indicating device for yarn crimping wheel teeth spacing adjustment 失效
    纱线卷曲轮齿间距调整指示装置

    公开(公告)号：US4007519A

    公开(公告)日：1977-02-15

    申请号：US594940

    申请日：1975-07-11

    申请人： Charles M. Rice

    发明人： Charles M. Rice

    IPC分类号： D02G1/14

    CPC分类号： D02G1/14

    摘要： In synthetic yarn texturing using crimping wheels, an indicating device is provided to aid in adjusting the peripheral spacing between the teeth of the wheels.

    摘要翻译： 在使用卷边轮的合成纱线纹理中，提供指示装置以帮助调节车轮齿之间的周边间距。

    Cell lines permissive for HCV replication
    9.
    发明授权
    Cell lines permissive for HCV replication 有权
    允许HCV复制的细胞系

    公开(公告)号：US07794942B2

    公开(公告)日：2010-09-14

    申请号：US11960391

    申请日：2007-12-19

    申请人： Charles M. Rice ,  Keril J. Blight

    发明人： Charles M. Rice ,  Keril J. Blight

    IPC分类号： C12Q1/68 ,  C12N15/00 ,  C12N5/10 ,  C12N15/51

    CPC分类号： C12Q1/707

    摘要： HCV variants are described. The variants include polynucleotides comprising non-naturally occurring HCV sequences and HCV variants that have a transfection efficiency and ability to survive subpassage greater than HCV that have wild-type polyprotein coding regions. Expression vectors comprising the above polynucleotides and HCV variants are also described, as are the provision of cells and host cells comprising the expression vectors. Methods for identifying a cell line that is permissive for infection with HCV are also provided, as are vaccines comprising the above polynucleotides in a pharmaceutically acceptable carrier. Additionally, methods for inducing immunoprotection to HCV in a primate are described, as are methods for testing a compound for inhibiting HCV replication.

    摘要翻译： 描述了HCV变体。 变体包括包含非天然存在的HCV序列和HCV变体的多核苷酸，其具有转染效率和能够存活大于具有野生型多蛋白编码区的HCV的亚临床的能力。 还描述了包含上述多核苷酸和HCV变体的表达载体，以及提供包含表达载体的细胞和宿主细胞。 还提供了鉴定用于感染HCV的细胞系的方法，以及在药学上可接受的载体中包含上述多核苷酸的疫苗。 此外，还描述了在灵长类动物中诱导HCV的免疫保护的方法，以及用于测试抑制HCV复制的化合物的方法。